NCT05036603

Brief Summary

Infants in the neonatal intensive care unit (NICU) may be lost due to risks such as being sensitive, frequent exposure to birth complications and being prone to infection. The most common causes of mortality in newborn babies in the world; Complications due to preterm delivery (28%), infections (26%) and perinatal asphyxia (23%) were reported. Respiratory problems are observed in 4-6% of newborns. These problems are also important causes of mortality in the neonatal period. Newborn infants are more likely to have respiratory distress due to difficulties in airway calibration, few collateral airways, flexible chest wall, poor airway stability, and low functional residual capacity.Invasive mechanical ventilation (IMV) is frequently used in the treatment of newborns with respiratory failure. Various ventilation modes and strategies are used to optimize mechanical ventilation and prevent ventilator-induced lung injury. Among the important issues to be considered in newborns connected to mechanical ventilator (MV); Choosing an appropriately sized endotracheal tube to reduce airway resistance and minimize respiratory workload, correct positioning, regular nursing care, chest physiotherapy, sedation-analgesia, and infection prevention are also included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 5, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

September 12, 2025

Status Verified

August 1, 2022

Enrollment Period

2.3 years

First QC Date

August 18, 2021

Last Update Submit

September 5, 2025

Conditions

Keywords

Newbornpretermchest physiotherapyneonatal intensive care unitmechanical ventilation

Outcome Measures

Primary Outcomes (10)

  • heart rate

    heart rate of the preterm newborns

    Before starting chest physiotherapy and up to15 minutes after ending therapy

  • chest X-Ray

    chest X-Ray of the preterm newborns

    on the 1st day before starting chest physiotherapy session and up to 24 hours after chest physiotherapy session

  • arterial blood gases

    arterial blood gases from the radial artery or from the umbilical catheter in infants with an umbilical catheter

    on the 1st day before starting chest physiotherapy session and up to 24 hours after chest physiotherapy session

  • PaO₂

    PaO₂ of the preterm newborns

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

  • blood pressure

    blood pressure of the preterm newborns

    on the time before starting chest physiotherapy and up to15 minutes after ending therapy

  • respiratory rate

    respiratory rate of the preterm newborns

    Before starting chest physiotherapy and up to15 minutes after ending therapy

  • Peep (cm H₂O)

    Peep (cm H₂O) of the preterm newborns

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

  • Pip (cm H₂O)

    Pip (cm H₂O) of the preterm newborns

    on the time before starting chest physiotherapy and up to15 minutes after ending therapy

  • FİO₂ (%/mm Hg)

    FİO₂ (%/mm Hg) of the preterm newborns

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

  • O₂ Saturation (mmHg) (SpO₂)

    O₂ Saturation (mmHg) (SpO₂) of the preterm newborns

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

Secondary Outcomes (4)

  • Chest shape and type (barrel/pektusexcavatum..etc)

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

  • Respiratory stress

    before physiotherapy

  • the respiratory pattern

    on the time before starting chest physiotherapy and up to 15 minutes after ending therapy

  • Daily nutrition type

    on the time before starting chest physiotherapy and up to 24 hours after chest physiotherapy

Study Arms (3)

1/routin medical care and neonatal intensive care unit's daily care

NO INTERVENTION

Group 1 (n=20) routine medical treatment for newborns on mechanical ventilator respiratory support and CPAP; Appropriate antibiotics given according to the needs of the baby, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care will be provided.

2/active chest physiotherapy in modified drainage positions

EXPERIMENTAL

Group 2 (n=20) newborns on mechanical ventilator respiratory support and CPAP; A single session of active chest physiotherapy (CP) will be applied using modified drainage positions (avoiding the trendelenburg position, excessive position change and avoiding hand contact in babies younger than 30 weeks or who are sensitive to position change). Active CP in various modified drainage positions; It will consist of percussion and vibration methods with proprioceptive replacement stimulations. After these methods, aspiration will be performed and a suitable position will be given to the lobe that is desired to be ventilated. In addition, these patients will be given routine medical treatment consisting of appropriate antibiotics, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care.

Other: chest physiotherapy

3/active chest physiotherapy in prone positions

EXPERIMENTAL

Group 3 (n=20) newborns on mechanical ventilator respiratory support and CPAP; a single session of active chest physiotherapy treatment to be applied only in the prone position; Starting with proprioceptive stimulation, percussion and vibration methods will be applied. After these methods, aspiration will be performed and a suitable position will be given to the lobe that is desired to be ventilated. In addition, these patients will be given routine medical treatment consisting of appropriate antibiotics, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care.

Other: chest physiotherapy

Interventions

diffferent chest physiotherapy methods

2/active chest physiotherapy in modified drainage positions3/active chest physiotherapy in prone positions

Eligibility Criteria

Age1 Day - 45 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm newborns born \<37 and \>28 weeks due to MV or CPAP, hospitalized in the NICU and with a voluntary consent form from their families (with segmental lobar collapse as a result of Chest X-Ray, RDS/BPD/HMH/Atelectasis/Pneumonia/ Preterm newborns diagnosed with Chronic Pulmonary Disease or in stable condition with a thick and secretory focus on X-ray)
  • First-time infants who have not received any chest physiotherapy program

You may not qualify if:

  • Newborn infants who have been unstable in the last 2 days (SpO₂ \<60 mmHg, heart rate, blood pressure, persistent apnea, excessive increases in respiratory rate, tachycardia, nasal wing breathing, cyanosis..etc)
  • Newborn infants with rib fracture, hemoptysis, diaphragmatic hernia, pulmonary hemorrhage, pneumothorax
  • Those diagnosed with any known heart disease or genetic disease
  • Those with osteopenia-osteoporosis or thrombocytopenia
  • Infants with any known neurological diagnosis (Abnormal MRI finding, Hydrocephalus, Chiari Malformation, Asphyxia, Periventricular Leukomolacia (PVL), Intraventricular Hemorrhage (IVH), Kernicterius, Hypoxic Ischemic Encephalopathy (HIE), Hydrocephalus)
  • Preterm infants weighing \<1000 g
  • Infants born with congenital anomaly (Spina Bifida, Arthrogryposis Multiplex Congenita..etc)
  • Newborns undergoing any surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kahramanmaras Sutcu Imam University

Kahramanmaraş, 46100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature BirthBronchopulmonary DysplasiaRespiratory Distress SyndromePulmonary AtelectasisHyaline Membrane Disease

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVentilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesRespiration DisordersRespiratory Distress Syndrome, Newborn

Study Officials

  • hatice Adiguzel, PhD

    Kahramanmaras Sutcu Imam University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 groups; different chest physitherapy approach and 1 grup(control): routine medical care for newborns and neonatal intensive care unit's routin daily care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Proffessor

Study Record Dates

First Submitted

August 18, 2021

First Posted

September 5, 2021

Study Start

April 1, 2022

Primary Completion

July 30, 2024

Study Completion

December 15, 2024

Last Updated

September 12, 2025

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

there is no plan to make individual participant data (IPD) available to other researchers.

Locations